Cargando…
Disrupting the endothelin and Wnt relationship to overcome chemoresistance
Knowledge of the mechanisms underlying chemoresistance is important in the development of novel targeted treatments for ovarian cancer. We recently reported that targeting endothelin A receptor/β-arrestin-1, a binding partner of Wnt/β-catenin, is sufficient to sensitize ovarian cancer to chemotherap...
Autores principales: | Rosanò, Laura, Bagnato, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905315/ https://www.ncbi.nlm.nih.gov/pubmed/27308478 http://dx.doi.org/10.4161/23723556.2014.995025 |
Ejemplares similares
-
LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018) -
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019) -
Chronic activation of DNA damage signals causes tumor immune evasion in the chemoresistant niche
por: Jinushi, Masahisa
Publicado: (2012) -
miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015) -
A perspective on DNA damage-induced potentiation of the pentose phosphate shunt and reductive stress in chemoresistance
por: Milanese, Chiara, et al.
Publicado: (2020)